According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -65,49ย โฌ. In 2022 the company made an earnings per share (EPS) of -107,45ย โฌ an increase over its 2021 EPS that were of -709,89ย โฌ.